[HTML][HTML] MiRNAs and LncRNAs: dual roles in TGF-β signaling-regulated metastasis in lung cancer
XN Lai, J Li, LB Tang, WT Chen, L Zhang… - International journal of …, 2020 - mdpi.com
Lung cancer is one of the most malignant cancers around the world, with high morbidity and
mortality. Metastasis is the leading cause of lung cancer deaths and treatment failure …
mortality. Metastasis is the leading cause of lung cancer deaths and treatment failure …
[图书][B] Physicians' Cancer Chemotherapy Drug Manual 2017
E Chu - 2016 - books.google.com
Written by world-class experts in clinical cancer therapeutics, Physicians' Cancer
Chemotherapy Drug Manual 2017 provides a complete, easy-to-use catalog of over 100 …
Chemotherapy Drug Manual 2017 provides a complete, easy-to-use catalog of over 100 …
Treatment of acute lymphoblastic leukaemia: a new era
E Apostolidou, R Swords, Y Alvarado, FJ Giles - Drugs, 2007 - Springer
Acute lymphocytic leukaemia (ALL) is a heterogeneous group of disorders that result from
the clonal proliferation and expansion of malignant lymphoid cells in the bone marrow …
the clonal proliferation and expansion of malignant lymphoid cells in the bone marrow …
[HTML][HTML] MicroRNA-21 regulates non-small cell lung cancer cell invasion and chemo-sensitivity through SMAD7
L Lin, H Tu, L Wu, M Liu, G Jiang - Cellular Physiology and …, 2016 - karger.com
Background/Aims: SMAD7 is a key inhibitor of transforming growth factor β (TGFβ) receptor
signaling, which regulates the alteration of cancer cell invasiveness through epithelial …
signaling, which regulates the alteration of cancer cell invasiveness through epithelial …
[HTML][HTML] Second-line chemotherapy with pemetrexed after gemcitabine failure in patients with advanced pancreatic cancer: a multicenter phase II trial
S Boeck, K Weigang-Köhler, M Fuchs, E Kettner… - Annals of oncology, 2007 - Elsevier
Background: A standard second-line chemotherapy regimen has yet to be defined for
patients with gemcitabine (Gem)-refractory advanced pancreatic cancer (PC). Patients and …
patients with gemcitabine (Gem)-refractory advanced pancreatic cancer (PC). Patients and …
[HTML][HTML] Current landscape of miRNAs and TGF‐β signaling in lung cancer progression and therapeutic targets
BM Hussen, SJ Saleem, SR Abdullah… - Molecular and Cellular …, 2023 - Elsevier
Lung cancer (LC) is the primary reason for cancer-associated fatalities globally. Due to both
tumor-suppressing and tumor-promoting activities, the TGF-β family of growth factors is …
tumor-suppressing and tumor-promoting activities, the TGF-β family of growth factors is …
培美曲塞治疗非小细胞肺癌临床研究进展
王晓光， 李金瀚， 罗荣城 - Zhongguo Fei Ai Za Zhi, 2005 - search.proquest.com
培美曲塞(pemetrexed disodium, A lim ta) 是一种∀ 多靶点抗叶酸制剂#,
由美国礼来公司作为抗代谢类抗癌药进行开发的. 这种抗代谢药物阻断了DNA …
由美国礼来公司作为抗代谢类抗癌药进行开发的. 这种抗代谢药物阻断了DNA …
[HTML][HTML] Pemetrexed single agent chemotherapy in previously treated patients with locally advanced or metastatic non-small cell lung cancer
F Russo, A Bearz, G Pampaloni… - BMC cancer, 2008 - Springer
Background The main objective of this study was to evaluate the safety of second-line
pemetrexed in Stage IIIB or IV NSCLC. Methods Overall, 95 patients received pemetrexed …
pemetrexed in Stage IIIB or IV NSCLC. Methods Overall, 95 patients received pemetrexed …
Thymidylate synthase inhibitors
Despite the development of a range of exciting novel agents in cancer therapy, thymidylate
synthase (TS) inhibitors remain pivotal in the management of many malignancies. Indeed, it …
synthase (TS) inhibitors remain pivotal in the management of many malignancies. Indeed, it …